A ssessment of the global burden of tuberculosis suggests that one-third of the world's population is infected with Mycobacterium tuberculosis. 9 Primary infection with the bacillus leads to active tuberculosis in a minority of individuals (about 10%), usually within 2 years of acquiring the organism. 5 In the remaining patients, the infection is usually controlled by the immune system and the individual remains asymptomatic, and the latency can persist throughout life. In circumstances in which the immune responses of the individual are perturbed, this latency may develop into active tuberculosis, so-called postprimary tuberculosis. Among those who develop active tuberculosis, tubercular osteomyelitis of the spine or Pott disease may be one of the myriad manifestations.
In the context of tubercular osteomyelitis of the spine, the disease presents a diagnostic dilemma, given the diverse causes of vertebral collapse, particularly in settings like ours in which the disease burden is high. Until recently, the tuberculin skin test was the only tool available for diagnosing tuberculosis infection. However, this test is limited by its low sensitivity (75-90%) and specificity due to the fact that the purified protein derivative used for skin testing is a conglomerate of more than 200 antigens that are widely shared among environmental mycobacteria and Mycobacterium bovis. 2, 4, 6 In an effort to develop more accurate tools for immunological diagnosis of tuberculosis, 2 mycobacterial proteins, culture filtrate protein and early secretory antigenic target (CFP10 and ESAT 6, respectively), have been evaluated. 9, 12 These proteins, encoded by genes located within the so-called region of differentiation (RD1) of the M. tuberculosis genome are specific for M. tuberculosis and, unlike purified protein derivative, are not shared with the Bacillus Calmette-Guérin strains of M. bovis and most environmental mycobacteria. Peripheral blood mononuclear lymphocytes of patients infected with M. tuberculosis secrete IFNγ when exposed to these antigens in vitro. 11, 13 Studies on these peptides have resulted in development of commercially available assays for tuberculosis infection (QuantiFERON TB, QuantiFERON TB gold, ELISPOT, and so on) that use the ELISA or ELISPOT technique.
The aim of the present study is 2fold: first, to evaluate whether this assay based on region of differentiation peptides is potentially useful for the diagnosis of Pott disease, particularly in situations in which there is diagnostic confusion among the causes of vertebral collapse; and second, to determine the efficacy of QuantiFERON assay along with a battery of tests consisting of TLC, ESR, bone scan, chest radiography, spine MR imaging, and bacteriological investigations in reaching a diagnosis of Pott disease and differentiating it from other causes of vertebral destruction.
Methods
This study included 70 consecutive patients with vertebral collapse. In some (59 patients) there was a suspicion of tuberculosis, while in others the cause could not be established clinically. All patients underwent a battery of tests including radiological evaluation (MR imaging and radiography of the chest and spine), routine blood workup (hemoglobin, TLC, differential leukocyte count, and ESR), ELISA for tuberculosis, bone scan, and the QuantiFERON assay (Cellestis).
Patients were finally deemed to have tuberculosis if the culture or AFB smear was positive for tuberculosis, there were strong clinical indications of tuberculosis (concomitant systemic focus, history of tuberculosis, and close contact), histology indicating tuberculosis (granulomatous inflammation and caseation), suggestive operative findings such as the presence of pus or granulation tissue accompanied by bone destruction, and therapeutic response to antituberculosis chemotherapy (rifampicin, isoniazid, ethambutol, and pyrazinamide) at follow-up.
The QuantiFERON gold test was performed according to the manufacturer's recommendations. The test consisted of a negative control (whole blood without antigens or mitogen), a positive control (mitogen well containing whole blood stimulated with the mitogen phytohemagglutinin [PHA]), and 2 sample wells (whole blood stimulated with either of the M. tuberculosis-specific antigens ESAT6 or CFP10). Whole blood specimens were incubated overnight at 37°C in a humidified atmosphere. The IFNγ level of the control well was considered background and was subtracted from the results of the mitogen well and the antigen-stimulated wells. The result of the test was considered positive if the concentration of IFNγ in the sample well after stimulation with ESAT6 and/or CFP10 was ≥ 0.35 IU/ml (after subtraction of the value of the control well), regardless of the result of the positive control (mitogen well). The result was considered negative if the response to the specific antigens (after subtraction of the value of the nil well) was < 0.35 IU/ml and if the IFNγ level of the positive control (after subtraction of the value of the control well) was ≥ 0.5 IU/ml.
Other patients in whom other causes, such as metastasis and primary bone tumors, were established, were determined to not have tuberculosis. The results of the IFN assay and other investigations in the battery were compared between these groups. In addition to these we included a group of 15 controls.
All patients included in the study underwent surgery, AFB smear examination, culture, and histopathological examination of the specimens. Blood samples were collected for the serological and hematological investigations as detailed above. Operative findings were recorded carefully to correlate with the final diagnosis. All patients with Pott disease who reported for follow-up underwent radiological investigations in the form of MR imaging and radiographs of the spine. Statistical methods used for analysis included the chi-square test and the z test for proportions.
Results
In our study 70 consecutive patients with vertebral collapse were evaluated. Based on the criteria listed above, tuberculosis was diagnosed in 51, and 40 of these patients were followed up for a mean duration of 3 months (range 6 weeks-18 months). In the remaining 19, the vertebral collapse was attributable to other causes.
The median age of the patients with tuberculosis was 38 years (range 19-58 years); 28 were men and 23 were women. The group that did not have tuberculosis had a median age of 41 years (range 21-62 years); 11 were men and 8 were women. The most common presenting symptoms in all patients were spasticity and motor weakness (37 patients [53%]); 25 patients (36%) had motor weakness without spasticity and 8 patients (11%) presented only with local pain or symptoms of posterior column impairment (Table 1) . On imaging studies 36 (70.5%) of the 51 patients with tuberculosis ( Table 2) showed patterns of paradiscal destruction with an associated soft-tissue component, either paraspinal or epidural. Chest radiographs revealed pulmonary foci in 9 of our patients.
Of patients classified as having tuberculous disease of the spine, 17 had positive findings on microscopy and 22 had positive findings on culture. The final results of QuantiFERON, radiological findings, culture, and smear are listed in Tables 2 and 3 .
The QuantiFERON assay was positive in 43 patients in whom tuberculosis was ultimately diagnosed (a total of 51 patients); among those with nontuberculous pathology (19 patients), it was positive in only 1 patient. The results in the control group (15 patients [9 men and 6 women]) were comparable to the 1 patient with tuberculosis but without vertebral pathology. Based on these data, sensitivity of the assay in diagnosis of tuberculosis of the spine was 84% and specificity was 95%. Among our patients with tuberculosis, the sensitivity of the AFB smear was 33% and that of culture was 43%. Taken together, these 2 tests had a combined sensitivity of 59% (29 patients) and the further addition of QuantiFERON to these resulted in a sensitivity of 88%, a difference that was statistically significant (p < 0.01). Of the 22 patients who had negative results by culture/smear, 19 were investigated further, and radiography and MR imaging of the spine showed good bony healing in these patients after chemotherapy. Of the remaining 3, 1 patient demonstrated typical granulomatous inflammation on histopathology, and in 2 the diagnosis was based on clinical criteria and operative findings as mentioned above.
Similarly IgG and IgM ELISA were positive in 41 and 15 of our patients, giving a sensitivity of 80 and 30%, respectively, and 2 of the patients without tuberculosis tested positive.
Among other investigations our patients underwent bone scanning. Bone scans showed a single-level uptake in 69% patients; 8% (4 patients) showed uptake at more than 1 level while as many as 24% of our patients were reported as having nonspecific tracer uptake that could not reliably distinguish spinal tuberculosis from degenerative processes (Table 4) .
Histopathology revealed granulomatous inflammation in 65% of our cases and was nonspecific in 27%. Analysis of the hematological workup revealed that the mean TLC in the patients with tuberculosis was 15,000/ mm 3 , and the mean ESR was 48 mm at 1 hour. Of 51 patients with a diagnosis of Pott disease, leukocyte counts were higher than 11,000 in 42 patients (sensitivity 82%), and the ESR was higher than 20 mm in 46 patients (sensitivity 90%). Comparing these findings with those in our patients without tuberculosis (19 patients), we found that 9 patients had elevated leukocyte counts and 10 (53%) had increased ESR. From this we infer a specificity of 47 and 53% for TLCs and ESR, respectively.
Having reviewed the results of individual investigations, we looked at the results in conjunction with each other and found a significant increase in the number of patients identified. Taken together, the sensitivity of the IFN assay, bone scan, ELISA, and imaging were predictive of tuberculous pathology in 90% of cases (46 patients). The leukocyte count and ESR were not included in the latter on account of poor specificity as mentioned above.
Discussion
A major hurdle in effective management of tuberculosis is diagnosis of the disease. Specifically, considering the problem of tuberculosis of the spine, in settings like ours with a high disease burden, the diagnostic dilemma often becomes acute with an inability to differentiate between the various causes of vertebral collapse that have a similar presentation. Given this background, it is expected that there will be an increasing use of in vitro assays to detect the presence of specific cellular responses to tuberculosis antigens. Several such methods are being developed and a few are commercially available, but their role in diagnosis and their reliability in excluding tuberculosis remains a subject of study and debate.
In the present study, 43 of 51 cases of Pott disease were positive for IFNγ and there was 1 positive finding among 19 patients proven to have vertebral collapse attributable to causes other than Pott disease. This difference was found to be statistically significant (p < 0.01).
The overall sensitivity of QuantiFERON in our study was 84%, and 83% (25 patients) among those in whom the findings were negative by both culture and smear. Among the 51 patients with tuberculosis of the spine, 17 were AFB positive and 22 were culture positive, yielding a sensitivity of 33 and 43%, respectively. This is expected given the significant bacterial loads required to facilitate detection on staining and culture using traditional methods (estimated to be 10 4 AFB μl and 10-100 AFB μl of specimen for smear and culture, respectively) 7 and the paucibacillary nature of the disease. When taken together, the sensitivity of smear and culture in identifying patients with the disease was 59% (30 patients). Thus, despite being the most specific modalities for confirming tuberculosis, the yield is quite modest. When we added the QuantiFERON assay to the diagnostic battery, we found that, taken together, smear, culture, and the IFN assay had a combined sensitivity of 87%.
As mentioned previously, on the basis of radiological findings we grouped these cases into those with a high probability of having tuberculosis (31 patients) and those with atypical features (10 patients). In the latter we found that the IFN assay had a sensitivity of 83% (8 patients). In other words, despite conflicting radiological findings, if the assay was relied upon for diagnosis, specific therapy targeting M. tuberculosis may have been started, thereby avoiding other interventions unless indicated for other reasons.
In addition to the above, among the 19 patients who eventually turned out to have vertebral involvement due to causes other than Pott disease, only 1 case was IFN positive, giving a specificity of 96%. The bone scans obtained in our patients showed a single level uptake in only 62.5% of our patients while in 25% they were nonspecific. It is thus difficult to commit to the diagnosis of tuberculosis based only on skeletal scans, although they may have a role in excluding a systemic malignancy with spinal involvement. Bone scanning may therefore be used as corroborative evidence to be interpreted in conjunction with the other investigations. It is known that, due to the indolent nature of the disease, bone scans may not pick up the disease until extensive bony destruction has already occurred.
14 This may explain the low yield in our study. Some, however, have reported a higher specificity of about 78%, which we have not been able to reproduce. It may be worthwhile to add here that in our patients, Tc-MDP was used as the tracer. Higher sensitivity might have been achieved with the use of Ga isotopes or a combination of the two. 13 Both ESR and TLC were sensitive, but when compared with the group without tuberculosis, specificity was rather poor (47 and 53%, respectively). Similar results have been published by other authors. 1, 8 Al-Marri and Kirkpatrick 1 demonstrated in a study of 144 pediatric patients with tuberculosis (pulmonary and extrapulmonary) that even though patients with symptomatic and smearpositive tuberculosis tended to have a higher ESR, the considerable overlap in values undermined the significance and diagnostic utility of individual values. Therefore, these parameters are too nonspecific to form a basis of diagnosis but there may be a role for ESR in following the effects of therapy on the disease process.
While the specificity of IgG ELISA was 89%, sensitivity was around 80%. In the literature available on ELISA, authors have reported sensitivities ranging from 54 to 80% for M. tuberculosis. 10, 12, 13 This variation may in part be explained by factors such as the disease prevalence in a particular community and proportion of immunocompromised subjects in the study group, among others.
Most studies examining the role of QuantiFERON assays have been conducted on patients with pulmonary tuberculosis. No substantial data were available on its role in tuberculosis of the spine. However, the sensitivity of the assays reported by other authors ranged from 82 to 93%. In a metaanalysis of studies on QuantiFERON assays by Pai et al., the pooled specificity of this assay was found to be 96%, which is comparable to the results derived from the present study. 9 Carrara et al. 3 have demonstrated the disappearance of IFNγ responses in patients who received therapy and persistent responses in patients who experienced failure of therapy. In another study Nicol et al. found that an early increase in responses to ESAT6 after 1 month of therapy was followed by a decrease in responses at 3 and 6 months of therapy. 8 This may suggest a role for the assay in following the effects of antituberculous therapy, but the pattern and decline in levels of the marker need further evaluation.
From these results, we can see that none of the investigative modalities taken individually are sufficiently specific or sensitive to form the sole basis of a diagnosis of Pott disease. While the most specific modalities are logically a positive culture or smear, these are plagued by a low yield of only about 58% when considered together. Similarly, the hematological indices are too nonspecific to be relied on for a definite diagnosis of tuberculosis of the spine. The QuantiFERON assay taken alone accurately predicted 84% of the cases. Therefore, if this is the only investigation relied on, one stands the risk of missing the diagnosis in about 16% of patients, which again is too high a figure to be acceptable. When QuantiFERON is considered in conjunction with MR imaging, bone scan, and ELISA, the yield increases to 90%. These may be adequate grounds to recommend this triad of investigations for a diagnosis of Pott disease. The test is available as an in-house investigation at our institution and is comparable in cost to ELISA. Although culture and smear are cheaper, their sensitivity remains an issue as previously discussed. QuantiFERON is therefore more cost effective than the other modalities available. Furthermore, patients who test negative for tuberculosis by the above methods need to be investigated more aggressively for an alternate diagnosis. In addition, those patients who do not have neurological deficits and test positive for tuberculosis need not undergo surgery or biopsy. In other words, a positive result by this triad would obviate the need for establishing a tissue diagnosis in the first instance, and these patients may be given a safe trial of antituberculous chemotherapy without significant risk of disease progression. In our study of 51 patients, 8 had minimal symptoms and underwent surgery with the objective of establishing a tissue diagnosis, and all tested positive for tuberculosis by the triad listed above. In retrospect, these patients might have been spared the trauma and expense of a procedure since all had tested positive for the IFN assay. The relative efficacy of the IFN assay in other forms of the disease, including CNS tuberculosis, is part of an ongoing study and should help better define the role of this investigation in the larger context of tuberculosis.
Limitations of the Study
In our study we excluded patients with HIV, AIDS, or other forms of immunosuppression. As might be anticipated, the efficacy of a Tcell-based assay may be lower in this subgroup of patients and the suitability of the assay needs to be further evaluated in them. Furthermore, some of the studies conducted on IFNγ release assays have found that antituberculosis therapy modifies the results of these assays. 10 Eight of our patients were started empirically on antituberculosis drugs for durations ranging from 8 to 12 weeks, and this could have resulted in underestimation of the actual positivity of the assay. Largerscale studies including greater numbers of patients with collapse due to causes other than tuberculosis would perhaps provide for a better intergroup comparison.
Conclusions
From the present study, it is apparent that none of the investigative modalities individually are sufficient to make a diagnosis of tuberculosis of the spine with a degree of certainty to obviate the need for a tissue diagnosis or bacteriological confirmation. However, when taken together, the battery consisting of the IFN assay, ELISA, MR imaging of the spine, and bone scan evaluated above provides a reasonably certain diagnosis in 90% of cases, providing the grounds for starting antituberculous chemotherapy. In addition to this, investigations may be important in ruling out tuberculosis as the etiological factor prompting a more aggressive evaluation for other causes such as metastatic disease, plasmacytoma, and primary bone tumors, among others. The ESR, which has been traditionally used as an index to diagnose and follow tuberculosis, was found to be nonspecific and cannot be recommended as a diagnostic test in this case. Its role in following patients with Pott disease who are receiving chemotherapy remains to be evaluated. We therefore recommend a battery consisting of IgG ELISA, Quanti FERON TB, MR imaging of the spine, and bone scan for a diagnosis of tuberculosis of the spine, and in those patients with negative results on the above battery the possibility of an alternate cause should be entertained and further investigations directed to that end.
